Home »
Rulemaking » Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New Drug Application 20-553 Were Withdrawn From Sale for Reasons of Safety or Effectiveness
Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New Drug Application 20-553 Were Withdrawn From Sale for Reasons of Safety or Effectiveness
Reference 10 Integrated Prevention Services for HIV Infection Viral Hepatitis Sexually Transmitted Diseases and Tuberculosis for Persons Who Use Drugs Illicitly Summary Guidance From the CDC and the US Department of Health and Human Services
View Attachment:
Title: Reference 10 Integrated Prevention Services for HIV Infection Viral Hepatitis Sexually Transmitted Diseases and Tuberculosis for Persons Who Use Drugs Illicitly Summary Guidance From the CDC and the US Department of Health and Human Services
Reference 11 Intranasal Hydrocodone Acetaminophen Abuse Induced Necrosis of the Nasal Cavity and Pharynx
View Attachment:
Title: Reference 11 Intranasal Hydrocodone Acetaminophen Abuse Induced Necrosis of the Nasal Cavity and Pharynx
Reference 2 Vital Signs Overdoses of Prescription Opioid Pain Relievers United States 1999 2008
View Attachment:
Title: Reference 2 Vital Signs Overdoses of Prescription Opioid Pain Relievers United States 1999 2008
Reference 3 Unintentional Drug Poisoning in the United States
View Attachment:
Title: Reference 3 Unintentional Drug Poisoning in the United States
Reference 4 Pharmaceutical Overdose Deaths, United States, 2010
View Attachment:
Title: Reference 4 Pharmaceutical Overdose Deaths, United States, 2010
Reference 5 FDA Blueprint for Prescriber Education for Extended Release and Long Acting Opioid Analgesics
View Attachment:
Title: Reference 5 FDA Blueprint for Prescriber Education for Extended Release and Long Acting Opioid Analgesics
Reference 6 Draft Guidance for Industry Abuse-Deterrent Opioids Evaluation and Labeling
View Attachment:
Title: Reference 6 Draft Guidance for Industry Abuse-Deterrent Opioids Evaluation and Labeling
Reference 7 Tampering With Prescription Opioids Nature and Extent of the Problem Health Consequences and Solutions
View Attachment:
Title: Reference 7 Tampering With Prescription Opioids Nature and Extent of the Problem Health Consequences and Solutions
Reference 8 Factors Associated With History of Non Fatal Overdose Among Young Nonmedical Users of Prescription Drugs
View Attachment:
Title: Reference 8 Factors Associated With History of Non Fatal Overdose Among Young Nonmedical Users of Prescription Drugs
Reference 9 Mortality Among Regular or Dependent Users of Heroin and Other Opioids A Systematic Review and Meta Analysis of Cohort Studies
View Attachment:
Title: Reference 9 Mortality Among Regular or Dependent Users of Heroin and Other Opioids A Systematic Review and Meta Analysis of Cohort Studies
Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New Drug Application 20-553 Were Withdrawn From Sale for Reasons of Safety or Effectiveness
Details Information
Attachments:
List of References
View Attachment:Reference 1 Policy Impact Prescription Painkiller Overdoses
View Attachment:Reference 10 Integrated Prevention Services for HIV Infection Viral Hepatitis Sexually Transmitted Diseases and Tuberculosis for Persons Who Use Drugs Illicitly Summary Guidance From the CDC and the US Department of Health and Human Services
View Attachment:Reference 11 Intranasal Hydrocodone Acetaminophen Abuse Induced Necrosis of the Nasal Cavity and Pharynx
View Attachment:Reference 2 Vital Signs Overdoses of Prescription Opioid Pain Relievers United States 1999 2008
View Attachment:Reference 3 Unintentional Drug Poisoning in the United States
View Attachment:Reference 4 Pharmaceutical Overdose Deaths, United States, 2010
View Attachment:Reference 5 FDA Blueprint for Prescriber Education for Extended Release and Long Acting Opioid Analgesics
View Attachment:Reference 6 Draft Guidance for Industry Abuse-Deterrent Opioids Evaluation and Labeling
View Attachment:Reference 7 Tampering With Prescription Opioids Nature and Extent of the Problem Health Consequences and Solutions
View Attachment:Reference 8 Factors Associated With History of Non Fatal Overdose Among Young Nonmedical Users of Prescription Drugs
View Attachment:Reference 9 Mortality Among Regular or Dependent Users of Heroin and Other Opioids A Systematic Review and Meta Analysis of Cohort Studies
View Attachment:Comments
Related Documents